PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

metronidazole Side Effects

The reactions most often reported to the FDA for metronidazole (also sold as Flagyl), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

63,731
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 1999 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of metronidazole come from 63,731 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 63,731 reports to the FDA Adverse Event Reporting System (FAERS) for metronidazole (Flagyl): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

63,731

Reports Mentioning Death

6,727

10.6% of reports — not proof the medicine caused the death

Hospitalizations

26,693

41.9% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

NAUSEA
4,693
DIARRHOEA
4,116
VOMITING
3,283
PYREXIA
3,224
DRUG HYPERSENSITIVITY
3,138
PAIN
3,129
ABDOMINAL PAIN
2,980
HEADACHE
2,882
FATIGUE
2,876
DYSPNOEA
2,238
DIZZINESS
2,201
CONDITION AGGRAVATED
2,107
MALAISE
2,017
RASH
1,997
ACUTE KIDNEY INJURY
1,846
WEIGHT DECREASED
1,827
ANXIETY
1,795
ASTHENIA
1,780

Who Reports Side Effects

Gender Distribution

Female 36,059 (62%)
Male 21,639 (37%)
Unknown 211

Age Distribution

0-17 3,086 (7%)
18-44 13,232 (29%)
45-64 14,581 (32%)
65-74 8,488 (18%)
75+ 6,765 (15%)

Reporting Trend by Year

1999 2025

Reactions in Death Reports

Top reactions reported in 6,727 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 1,067
SEPSIS 823
MULTIPLE ORGAN DYSFUNCTION SYNDROME 639
SEPTIC SHOCK 523
NAUSEA 521
VOMITING 507
ABDOMINAL PAIN 506
GENERAL PHYSICAL HEALTH DETERIORATION 492
PNEUMONIA 472
RENAL FAILURE 467
PYREXIA 461
CONDITION AGGRAVATED 445
ANAEMIA 439
DYSPNOEA 418
DIARRHOEA 394
RESPIRATORY FAILURE 375
ASCITES 374
ABDOMINAL DISTENSION 356

Reactions in Hospitalization Reports

Top reactions in 26,693 reports where hospitalization was an outcome.

Reaction Reports
DIARRHOEA 2,191
NAUSEA 2,138
PYREXIA 2,084
VOMITING 1,845
ABDOMINAL PAIN 1,842
PAIN 1,700
DYSPNOEA 1,303
ANAEMIA 1,248
FATIGUE 1,167
ACUTE KIDNEY INJURY 1,103
WEIGHT DECREASED 1,087
ASTHENIA 1,080
HEADACHE 1,080
CONDITION AGGRAVATED 1,062
MALAISE 1,058
PNEUMONIA 1,027
SEPSIS 996
DIZZINESS 834

Compare metronidazole vs amikacin →

What the FAERS Data Reveals About metronidazole Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 63,731 voluntary reports linked to metronidazole and its brand equivalents (Flagyl), spanning 1999 through 2025. Of those, 6,727 (10.6%) listed death as an outcome and 26,693 (41.9%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 62% were female and 37% male; age distribution skews toward 45-64, with 14,581 reports in that bracket. The single most reported reaction is nausea with 4,693 submissions, followed by diarrhoea and vomiting.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.